[1. D. Klose, F. Siepmann, J. F. Willart, M. Descamps and J. Siepmann, Drug release from PLGA-based microparticles: Effects of the “microparticle:bulk fluid” ratio, Int. J. Pharm. 383 (2010) 123-131; DOI: 10.1016/j.ijpharm.2009.09.012.10.1016/j.ijpharm.2009.09.012]Search in Google Scholar
[2. C. Regnier-Delplace, O. Thillaye Du Boullay, F. Siepmann, B. Martin-Vaca, N. Degrave, P. Demonchaux, O. Jentzer, D. Bourissou and J. Siepmann, PLGA microparticles with zero-order release of the labile anti-Parkinson drug apomorphine, Int. J. Pharm. 443 (2013) 68-79; DOI: 10.1016/j. ijpharm.2013.01.008.]Search in Google Scholar
[3. C. Wischke and S. P. Schwendeman, Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles, Int. J. Pharm. 364 (2008) 298-327; DOI: 10.1016/j.ijpharm.2008.04.042.10.1016/j.ijpharm.2008.04.042]Search in Google Scholar
[4. D. Klose, C. Delplace and J. Siepmann, Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles, Int. J. Pharm. 404 (2011) 75-82; DOI: 10.1016/j.ijpharm.2010.10.054.10.1016/j.ijpharm.2010.10.054]Search in Google Scholar
[5. D. Klose, F. Siepmann, K. Elkharraz, S. Krenzlin and J. Siepmann, How porosity and size affect the drug release mechanisms from PLGA-based microparticles, Int. J. Pharm. 314 (2006) 198-206; DOI: 10.1016/j.ijpharm.2005.07.031.10.1016/j.ijpharm.2005.07.031]Search in Google Scholar
[6. S. Freitas, H. P. Merkle and B. Gande, Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology, J. Control. Release 102 (2005) 313-332; DOI: 10.1016/j.jconrel.2004.10.015.10.1016/j.jconrel.2004.10.015]Search in Google Scholar
[7. I. D. Rosca, F. Watari and M. Uo, Microparticle formation and its mechanism in single and double emulsion solvent evaporation, J. Control. Release 99 (2004) 271-280; DOI: 10.1016/j.jconrel.2004.07.007.10.1016/j.jconrel.2004.07.007]Search in Google Scholar
[8. G. Paskaris and N. Bouropoulos, Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads, Int. J. Pharm. 323 (2006) 34-42; DOI: 10.1016/j. ijpharm.2006.05.054.]Search in Google Scholar
[9. S. B. Wang, A. Z. Chen, L. J. Weng, M. Y. Chen and X. L. Xie, Effect of drug-loading methods on drug load, encapsulation efficiency and release properties of alginate/poly-L arginine/chitosan ternary complex microcapsules, Macromol. Biosci. 4 (2004) 27-30; DOI: 10.1002/mabi.200300043.10.1002/mabi.200300043]Search in Google Scholar
[10. M. Song, N. Li, S. Sun, L. R. Tiedt, W. Liebenberg and M. M. de Villiers, Effect of viscosity and concentration of wall former, emulsifier and pore-inducer on the properties of amoxicillin microcapsules prepared by emulsion solvent evaporation, Il. Farmaco. 60 (2005) 261-267; DOI: 10.1016/j. farmac.2004.11.009.]Search in Google Scholar
[11. D. Vetchý, M. Vetchá, M. Rabišková, E. Gryczová and L. Bartošíková, Comparison in vitro felodipine release rate from the original versus generic product with controlled release of the drug, Medicina (Kaunas). 43 (2007) 326-331.10.3390/medicina43040040]Search in Google Scholar
[12. V. P. Shah, Y. Tsong, P. Sathe and J. P. Liu, In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2, Pharm. Res. 15 (1998) 889-896; DOI: 10.1023/A:1011976615750.10.1023/A:1011976615750]Search in Google Scholar
[13. K. H. Esbensen, D. Guyot, F. Westad and L. P. Houmoller: Multivariate data analysis: in practice: an introduction to multivariate data analysis and experimental design, CAMO AS Publications, Oslo 2004, pp. 598.]Search in Google Scholar
[14. P. Sansdrap and A. J. Moes, Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly (DL-lactide-co-glycolide) microspheres, Int. J. Pharm. 98 (1993) 157-164; DOI: 10.1016/0378-5173(93)90052-H.10.1016/0378-5173(93)90052-H]Search in Google Scholar
[15. M. Hamoudeh and F. Hatem, Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles, J. Colloid. Interf. Sci. 300 (2006) 584-590; DOI: 10.1016/j. jcis.2006.04.024.]Search in Google Scholar
[16. S. Tamilvanan, Effect of production variables on the physical characteristics of ibuprofen-loaded polystyrene microparticles, J. Microencapsul. 16 1999 411-418; DOI: 10.1080/026520499288870.10.1080/026520499288870]Search in Google Scholar
[17. Y. Y. Yang, T. Chung and N. P. Ng, Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method, Biomaterials 22 (2001) 231-241; DOI: 10.1016/S0142-9612(00)00178-2.10.1016/S0142-9612(00)00178-2]Search in Google Scholar
[18. R. M. Mainardes and R. C. Evangelista, PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution, Int. J. Pharm. 290 (2005) 137-144; DOI: 10.1016/j. ijpharm.2004.11.027.]Search in Google Scholar
[19. T. Freytag, A. Dashevsky, L. Tillman, G. E. Hardee and R. Bodmeier, Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres, J. Control. Release 69 (2000) 197-207; DOI: 10.1016/S0168-3659(00)00299-6.10.1016/S0168-3659(00)00299-6]Search in Google Scholar
[20. P. B. O’Donnell and J. W. McGinity, Preparation of microspheres by the solvent evaporation technique, Adv. Drug Deliv. Rev. 28 (1997) 25-42; DOI: 10.1016/S0169-409X(97)00049-5. 10.1016/S0169-409X(97)00049-5]Search in Google Scholar
[21. Y. Capan, B. H. Woo, S. Gebrekidan, S. Ahmed and P. P. DeLuca, Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA, J. Control. Release 60 (1999) 279-286; DOI: 10.1016/S0168-3659(99)00076-0.10.1016/S0168-3659(99)00076-0]Search in Google Scholar
[22. S. Mao, Y. Shi, L. Li, J. Xu, A. Schaper and T. Kissel, Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method, Eur. J. Pharm. Biopharm. 68 (2008) 214-223; DOI: 10.1016/j. ejpb.2007.06.008.]Search in Google Scholar
[23. M. Li, O. Rouaud and D. Poncelet, Microencapsulation by solvent evaporation: State of the art for process engineering approaches, Int. J. Pharm. 363 (2008) 26-39; DOI: 10.1016/j.ijpharm.2008.07.018.10.1016/j.ijpharm.2008.07.018]Search in Google Scholar
[24. S. Fredenberg, M. Wahlgren, M. Reslow and A. Axelsson, The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - A review, Int. J. Pharm. 415 (2011) 34-52; DOI: 10.1016/j.ijpharm.2011.05.049.10.1016/j.ijpharm.2011.05.049]Search in Google Scholar
[25. N. S. Berchane, K. H. Carson, A. C. Rice-Ficht and M. J. Andrews, Effect of mean diameter and polydispersity of PLG microspheres on drug release: Experiment and theory, Int. J. Pharm. 337 (2007) 118-126; DOI: 10.1016/j.ijpharm.2006.12.037.10.1016/j.ijpharm.2006.12.037]Search in Google Scholar
[26. C. Berkland, K. Kim and D. W. Pack, PLG Microsphere size controls drug release rate through several competing factors, Pharmaceut. Res. 20 (2003) 1055-1062; DOI: 10.1023/A:1024466407849.10.1023/A:1024466407849]Search in Google Scholar
[27. X. Huang and C. S. Brazel, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems, J. Control. Release 73 (2001) 121-136. 10.1016/S0168-3659(01)00248-6]Search in Google Scholar